Iview Therapeutics Inc.
Clinical trials sponsored by Iview Therapeutics Inc., explained in plain language.
-
New gel takes on pink eye in Head-to-Head trial
⭐️ CURE ⭐️ CompletedThis study tested a new gel called IVIEW 1201 against standard antibiotic eye drops for treating bacterial pink eye. 129 people with acute bacterial conjunctivitis took part. The goal was to see if the gel works better at clearing up redness and discharge by day 8 and day 14.
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:01 UTC
-
New eye gel shows promise against stubborn pink eye
Disease control CompletedThis study tested a new eye gel called IVIEW-1201 in 135 people with acute adenoviral conjunctivitis (pink eye caused by a virus). The goal was to see if the gel could clear symptoms like redness and discharge faster than a placebo. The gel contains povidone-iodine, an antiseptic…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a simple eyelid wipe soothe dry eyes?
Symptom relief CompletedThis study tested three ways to use an eyelid wipe soaked with IVW-1001, a dry eye treatment, in 30 people with dry eye disease. Researchers measured changes in tear production and checked for any vision changes. The goal was to find the best wiping technique for safety and sympt…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New eyelid wipe dosing methods tested for dry eye relief
Symptom relief CompletedThis study tested three different ways to use a medicated eyelid wipe (IVW-1001) for people with dry eye disease. Fifteen adults with dry eye took part. The main goal was to see how safe and tolerable the different dosing techniques were, and how well they improved tear productio…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New eyelid wipe aims to soothe dry eyes
Symptom relief CompletedThis study tested a new medicated eyelid wipe called IVW-1001 in 150 adults with dry eye disease. Participants used either a low dose, a higher dose, or a placebo wipe. The goal was to see if the wipe is safe and can improve tear production and eye comfort.
Phase: PHASE1, PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC